Vericel Corp. (VCEL)
35.15
-0.25
(-0.71%)
USD |
NASDAQ |
May 21, 16:00
35.12
-0.03
(-0.09%)
After-Hours: 19:59
Vericel EPS Diluted (Quarterly) : -0.1241 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Arbutus Biopharma Corp. | 0.8693 |
| Tenaya Therapeutics, Inc. | -0.0889 |
| Moderna, Inc. | -3.40 |
| Curis, Inc. | -1.250 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.302M |
| Revenue (Quarterly) | 68.42M |
| Total Expenses (Quarterly) | 74.73M |
| Enterprise Value | 1.746B |
| Gross Profit Margin (Quarterly) | 72.00% |
| Profit Margin (Quarterly) | -9.21% |
| Earnings Yield | 1.16% |
| Operating Earnings Yield | 0.88% |
| Normalized Earnings Yield | 1.164 |